COOPER LIFE SCIENCES INC
10-Q, 1995-03-14
MORTGAGE BANKERS & LOAN CORRESPONDENTS
Previous: FIDELITY SECURITIES FUND, N-30D, 1995-03-14
Next: MORRISON KNUDSEN CORP, 8-K, 1995-03-14



<PAGE>

                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-Q

(Mark One)

[X]  QUARTERLY  REPORT  PURSUANT  TO  SECTION  13 OR 15 (d)  OF  THE  SECURITIES
     EXCHANGE ACT OF 1934

For the quarterly period ended JANUARY 31, 1995

                                       or

[ ]  TRANSITION  REPORT  PURSUANT  TO  SECTION  13 OR 15 (d)  OF THE  SECURITIES
     EXCHANGE ACT OF 1934

For the transition period from ________________ to _______________________

Commission file number:  0-13649

                           COOPER LIFE SCIENCES, INC.
             (Exact name of registrant as specified in its charter)

DELAWARE                                               94-2563513
(State or other jurisdiction of                  (I.R.S. Employer
incorporation or organization)                   Identification No.)

160 BROADWAY, NEW YORK, NEW YORK                    10038
(Address of principal executive offices)         (Zip Code)

Registrant's telephone number, including area code: (212) 791-5362

     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the  Securities  Exchange Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days. Yes _X_ No ___

     As of March  10,  1995,  there  were  2,111,695  outstanding  shares of the
issuers Common Stock, $.10 par value.


<PAGE>


                  COOPER LIFE SCIENCES, INC. AND SUBSIDIARIES
                         QUARTERLY REPORT ON FORM 10-Q

                                     INDEX


<TABLE>
<CAPTION>
                                                                        PAGE NO.
                                                                        --------
<S>      <C>                                                            <C>
         PART I.           FINANCIAL INFORMATION
Item 1.           Financial Statements

                  Consolidated Balance Sheets as of
                  January 31, 1995 and October 31, 1994                        3

                  Consolidated Statements of Operations
                  For The Three Months Ended
                  January 31, 1995 and 1994                                    4

                  Condensed Statements of Consolidated
                  Cash Flows For The Three Months Ended
                  January 31, 1995 and 1994                                    5

                  Notes to Consolidated Condensed
                  Financial Statements                                         6

Item 2.           Management's Discussion and Analysis
                  of Financial Condition and Results
                  of Operations                                                8

         PART II           OTHER INFORMATION

Item 6.           Exhibits and Reports on Form 8-K                            10

Signature                                                                     11
</TABLE>

                                       2

<PAGE>

                  COOPER LIFE SCIENCES, INC. AND SUBSIDIARIES
                          CONSOLIDATED BALANCE SHEETS
                             (DOLLARS IN THOUSANDS)
                                  (UNAUDITED)

<TABLE>
<CAPTION>
                                                      JANUARY 31,    OCTOBER 31,
                                                         1995           1994
                                                      -----------    -----------
<S>                                                   <C>            <C>
         ASSETS

Cash and cash equivalents                                $    636      $    444
Marketable Securities - The Cooper
 Companies, Inc. Common Stock                              18,669        19,602
Prepaid expenses and other                                    107            53
Property and equipment, net                                    42            45
Net assets of discontinued operations                       5,081        22,438
                                                         --------      --------
                                                         $ 24,535      $ 42,582
                                                         ========      ========

         LIABILITIES AND STOCKHOLDERS' EQUITY

Bank borrowings - warehouse lines of credit                $   --      $ 18,034
                  other                                     1,500         1,500
Notes payable - affiliates                                   --           2,300
Accounts payable and other accrued liabilities              1,254         1,329
                                                         --------      --------
                                                            2,754        23,163

Minority interest                                              --            --

Stockholders' Equity
 Preferred stock - $.10 par value: 6,000,000
  shares authorized: none issued                               --            --
 Common stock - $.10 par value: 6,000,000
  shares authorized: 2,516,095 shares issued:
  2,111,695 shares and 2,109,695 shares
  outstanding at January 31, 1995 and
  October 31, 1994, respectively                              251           251
Additional paid-in capital                                 78,283        78,283
Unrealized gain on marketable securities                    4,851         5,783
Accumulated deficit                                       (59,025)      (62,293)

Less: Common stock in treasury - at cost;
 404,400 shares and 406,400 shares
 at January 31, 1995 and
 October 31, 1994, respectively                            (2,104)       (2,130)
Minimum pension liability adjustment                         (475)         (475)
                                                         --------      --------
Total Stockholders' Equity                                 21,781        19,419
                                                         --------      --------
                                                         $ 24,535      $ 42,582
                                                         ========      ========
</TABLE>



            SEE NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

                                       3

<PAGE>


                  COOPER LIFE SCIENCES, INC. AND SUBSIDIARIES
                     CONSOLIDATED STATEMENTS OF OPERATIONS
                    (IN THOUSANDS, EXCEPT PER SHARE FIGURES)
                                  (UNAUDITED)


<TABLE>
<CAPTION>
                                                      FOR THE THREE MONTHS ENDED
                                                              JANUARY 31,
                                                      --------------------------
                                                         1995            1994
                                                      ----------       ---------
<S>                                                     <C>            <C>
         Revenues

Interest income                                         $      8             --
Unrealized loss on marketable securities                      --           (606)
Other income                                                   4             --
                                                        --------       --------
                                                              12           (606)
                                                        --------       --------

         Expenses
General and administrative                                   356            276
Interest                                                      38             72
                                                        --------       --------
         Total expenses                                      394            348
                                                        --------       --------

(Loss) from continuing
 operations before income taxes                             (382)          (954)
Provision for income taxes                                    --              2
                                                        --------       --------
(Loss) from continuing operations                           (382)          (956)

Gain on sale of and results from
 discontinued operations before
 income taxes                                              3,650           (651)
Provision for income taxes                                    --             --
                                                        --------       --------
Results from discontinued operations                       3,650           (651)
                                                        --------       --------

Net income (loss)                                       $  3,268       $ (1,607)
                                                        ========       ========

Net income (loss) per share
 Continuing operations                                  $   (.17)      $   (.48)
 Discontinued operations                                    1.64           (.33)
                                                        --------       --------

Net income (loss) per share                             $   1.47       $   (.81)
                                                        ========       ========

Average number of shares outstanding                       2,222          1,989
                                                        ========       ========
</TABLE>


            SEE NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

                                       4

<PAGE>

                  COOPER LIFE SCIENCES, INC. AND SUBSIDIARIES
                CONDENSED STATEMENTS OF CONSOLIDATED CASH FLOWS
                                 (IN THOUSANDS)
                                  (UNAUDITED)

<TABLE>
<CAPTION>
                                                            THREE MONTHS ENDED
                                                                 JANUARY 31,
                                                           ---------------------
                                                             1995        1994
                                                           --------    ---------
<S>                                                        <C>         <C>      
  Cash flows from operating activities:
 Net income (loss)                                         $  3,268    $ (1,607)
 Adjustments to reconcile net income (loss) to net
  cash provided by (used in) operating activities:
 (Income) loss on discontinued operations                    (3,650)        651
 Unrealized loss on marketable securities                        --         606
 Depreciation and amortization                                    3          25
  Changes in assets and liabilities:
 (Increase) in prepaid expenses and other                       (53)        (14)
 (Increase) in accounts payable and other
  accrued liabilities                                           (75)       (239)
                                                           --------    --------
 Net (used in) operating activities                            (507)       (578)
                                                           --------    --------
  Cash flows from investing activities: 
 Cash from sale of discontinued operations                   21,006          --
 Issuance of common stock from treasury                          26          --
                                                           --------    --------
 Net cash provided by investing activities                   21,032          --
                                                           --------    --------
  Cash flows from financing activities:
 (Decrease) in notes payable - affiliate                     (2,300)         --
 Payment of warehouse borrowing                             (18,033)         --
 Increase in bank borrowing                                      --         500
                                                           --------    --------
 Net cash provided by (used in) financing activities        (20,333)        500
                                                           --------    --------
 Net increase (decrease) in cash and cash equivalents           192         (78)
 Cash and cash equivalents - Beginning of period                444         150
                                                           --------    --------
 Cash and cash equivalents - End of period                 $    636    $     72
                                                           ========    ========

SUPPLEMENTAL CASH FLOW INFORMATION:
 Cash used to pay interest                                 $     38    $     72
 Cash used to pay taxes                                          --          --
</TABLE>



            SEE NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS


                                       5

<PAGE>




                  COOPER LIFE SCIENCES, INC. AND SUBSIDIARIES
              NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
                           JANUARY 31, 1995 AND 1994

NOTE 1. - BUSINESS OF THE COMPANY

ACQUISITIONS

     On February  28,  1995,  Unistar  Gaming  Corp.  ("UGC")  acquired  Unistar
Entertainment,  Inc., a privately held Colorado corporation ("Unistar"). Unistar
holds an  exclusive  contract  with the Coeur  d'Alene  Indian Tribe in Idaho to
develop  and  manage  what  would be the first  national  lottery  in the United
States.  As a result  of the  acquisition,  approximately  27.5  percent  of the
outstanding Common Stock of UGC is now owned by Cooper Life Sciences,  Inc. (the
"Company"),  and approximately  72.5 percent of the outstanding  Common Stock of
UGC is now owned by the former  stockholders  of  Unistar.  The shares of Common
Stock which are owned by the Company were purchased by it for $5 million.

     Upon the  completion of the  Securities  and Exchange  Commission  approval
process,  substantially all of the shares of Common Stock of UGC which are owned
by the Company will be  distributed,  on a one for one basis,  to the  Company's
stockholders  of record on the record date for the  distribution  (which has not
yet  been  determined).  The  distribution  will  be in the  form  of a  taxable
spin-off.  At that time,  the shares of UGC which had been owned by the  Company
will be owned by its individual stockholders. Thereafter, UGC (which owns all of
Unistar) will carry on its business as an independent  public  corporation.  The
Company  has been  granted  the  right,  for a six  year  period,  to  designate
one-third of the members of the Board of Directors of UGC.

DISPOSITIONS

     On November 30, 1994, the Company sold  substantially  all of the assets of
its  mortgage  banking  business.  As a result of this sale the  Company  is not
presently  engaged in any  business  operations  (other  than  certain  mortgage
servicing activities which it still retains, but which it plans to dispose of).

     The Company is currently  investigating new business  opportunities  (other
than the transaction described above.)

     The consolidated  financial  statements include the accounts of Cooper Life
Sciences, Inc. and its majority-owned subsidiaries. All significant intercompany
accounts and  transactions  have been  eliminated.  Certain  amounts in the 1994
financial  statements  have been  reclassified  to conform to the current year's
presentation.

     In  the  opinion  of  management,   the  accompanying  unaudited  financial
statements contain all adjustments  (consisting of normal recurring adjustments)
considered  necessary to present  fairly the  Company's  consolidated  financial
position  as of January  31,  1995 and  October  31,  1994 and the  consolidated
results of its operations for the three month periods ended January 31, 1995 and
1994, and its consolidated  cash flows for the three month periods ended January
31, 1995 and 1994.

NOTE 2. - SIGNIFICANT ACCOUNTING POLICIES

     Net income per share is  determined  using the weighted  average  number of
common and common equivalent shares outstanding  during the respective  periods,
including the incremental shares from the dilutive effects of warrants and stock
options. Common stock equivalents have not been included in the determination of
net loss per share as they are antidilutive.

                                       6

<PAGE>


                  COOPER LIFE SCIENCES, INC. AND SUBSIDIARIES
        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS - CONTINUED
                           JANUARY 31, 1995 AND 1994

     On October 31, 1994, the Company adopted Statement of Financial  Accounting
Standards  No.  115  "Accounting  for  Certain  Investments  in Debt and  Equity
Securities"  ("SFAS  No.  115").  In  accordance  with  SFAS  No.  115,  Company
management  determines the appropriate  classification of securities at the time
of purchase and  reevaluates  such  designation  as of each balance  sheet date.
Marketable  equity  securities  not held as trading  assets in  anticipation  of
short-term    market    movements   are   classified   as    available-for-sale.
Available-for-sale  securities  are carried at fair value,  with the  unrealized
gains and losses,  net of tax, reported in a separate component of shareholders'
equity.  The cost of  securities  sold is based on the average cost  method.  At
January  31,  1995,  the  Company  considers  all of its  holdings of The Cooper
Companies,  Inc. common stock (the "TCC Common Stock") to be  available-for-sale
securities  and, as such, are carried at fair value,  with the unrealized  gains
and  losses,  net of tax,  reported  in a separate  component  of  shareholders'
equity.  Changes in the valuation  allowance  resulting from unrealized gains or
losses on the TCC Common Stock have been recorded in the statement of operations
prior to the adoption of SFAS No. 115 on October 31, 1994.  At January 31, 1995,
the Company owned 7,467,600 shares of TCC Common Stock.

     The Company owns  approximately 22% of the outstanding TCC Common Stock and
intends to  liquidate  its  holdings of TCC Common  Stock in an orderly  fashion
which should result in a holding of less than 20% of the  outstanding TCC Common
Stock.  Accordingly,  management believes that fair value is the most meaningful
method of valuing this investment.

NOTE 3. - DISCONTINUED OPERATIONS

     On  October  31,  1994,  management  of the  Company  formulated  a plan to
discontinue  its mortgage  banking  business.  Accordingly  the entire  mortgage
banking operations of the Company's majority owned subsidiary, Entrust Financial
Corporation  ("Entrust"),  have been  considered a discontinued  operation as of
October 31, 1994.

     On November 30, 1994,  pursuant to an Asset Purchase  Agreement dated as of
November 23, 1994 by and between The Long Island  Savings Bank, FSB ("LISB") and
Entrust  (the  "Asset  Purchase  Agreement"),  Entrust  sold to LISB its  entire
origination business,  including mortgage loans held for sale and mortgage loans
in process, a substantial portion of its rights to service loans for others, and
a  substantial  portion  of its fixed  assets.  Pursuant  to the Asset  Purchase
Agreement,  LISB assumed the prospective obligations and duties of Entrust under
certain  contracts and leases relating to the assets acquired by it. Most of the
liabilities and prospective obligations relating to Entrust's administrative and
servicing  operations  have been retained by Entrust.  Since  November 30, 1994,
Entrust has and will continue to act as a subservicer of mortgage loans for LISB
for an interim period.

     The gross  purchase  price  realized  by  Entrust  in the  transaction  was
approximately $31 million in cash, which after repayment of indebtedness related
to the business  (including  repayment  to two officers and  directors of Second
Advantage of  approximately  $1.0 million  principal  amount of indebtedness for
borrowed money and approximately $17.8 million to its principal lender to retire
its warehouse and credit facility secured  indebtedness) will result in net sale
proceeds to Entrust of approximately  $11.0 million.  The Company estimates that
the gain on such sale will amount to approximately  $3.9 million.  As of January
31,  1995,  approximately  $30 million of the purchase  price  proceeds had been
received  by  Entrust,   $18.8   million  of  which  has  been  used  to  retire
indebtedness.  The balance of the purchase price (excluding  $750,000 which will
be retained in

                                       7

<PAGE>

                  COOPER LIFE SCIENCES, INC. AND SUBSIDIARIES
        NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS - CONTINUED
                           JANUARY 31, 1995 AND 1994

escrow as security for the performance or payment of indemnification obligations
of Entrust to LISB, if any) is expected to be paid to Entrust in March 1995.

     Management  of the  Company  plans to dispose of the Ohio  Housing  Finance
Agency  backed  mortgage  portfolio,  of  approximately  $282 million  principal
amount,  which has a book value of  approximately  $4.7  million at January  31,
1995, as market conditions permit.

     The results of the  discontinued  operations  for the quarter ended January
31, 1995 and January 31, 1994 are summarized as follows:

<TABLE>
<CAPTION>

                                      January 31,
                             ----------------------------
                                1995              1994
                             -----------      -----------
<S>                          <C>              <C>
Revenue                      $   230,000      $ 3,820,000
Net loss                        (393,000)      (1,277,000)
Gain on sale to LISB,
 net of income taxes           7,743,000               --
                             -----------      -----------
Net income (loss)              7,350,000       (1,277,000)
Gain (loss) allocable
 to the Company                3,748,000         (651,000)
Amortization of goodwill         (98,000)              --
                             -----------      -----------
                               3,650,000         (651,000)
Gain (loss) per share        $      1.77      $      (.33)
</TABLE>

NOTE 3. - BORROWINGS

     In August 1993, the Company borrowed $1,500,000 from a bank the proceeds of
which were utilized in connection with the  acquisition of the mortgage  banking
business  which was payable on January 31, 1995.  In January  1995,  the Company
renewed the loan which is currently  payable on May 1, 1995.  In November  1993,
the Company arranged a $500,000  revolving line of credit facility with the bank
which  expires on May 1, 1995.  At January 31,  1995,  there were no  borrowings
against  the  revolving  line of  credit  facility.  The loan and line of credit
facility  bear interest at the bank's prime rate (8.5% at January 31, 1995) plus
1.5%.  Payment of the loan and revolving  line of credit is secured by shares of
The Cooper Companies, Inc. Common Stock owned by the Company.

ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
         CONDITION AND RESULTS OF OPERATIONS.

GENERAL

     On  October  31,  1994,  management  of the  Company  formulated  a plan to
discontinue its mortgage  origination and servicing  business which was acquired
in August 1993 and on November  30, 1994 the Company  sold the  majority of such
business (see Note 3 of Notes to Consolidated  Condensed Financial  Statements).
Accordingly,  the results of the entire mortgage  banking  operations of Entrust
have been considered a discontinued operation for the three months ended January
31, 1995.  References  to the  "Company"  herein shall be deemed to refer to the
Company and its consolidated subsidiaries unless the context otherwise requires.

RESULTS OF  OPERATIONS  FOR THE THREE MONTHS ENDED  JANUARY 31, 1995 COMPARED TO
THE THREE MONTHS ENDED JANUARY 31, 1994

     DISCONTINUED  OPERATIONS.  For the three months ended January 31, 1995, net
income from discontinued  operations was  approximately  $3,650,000 and includes
the gain on the sale of the business to LISB in November 1994.

                                       8

<PAGE>


         MANAGEMENT'S   DISCUSSION  AND  ANALYSIS  OF  FINANCIAL  CONDITION  AND
         RESULTS OF OPERATIONS. - CONTINUED

     COSTS AND  EXPENSES.  Total  expense for the three months ended January 31,
1995 was $394,000 as compared to $348,000 for the three months ended January 31,
1994.

     The  Company's  general and  administrative  expenses  for the three months
ended January 31, 1995  increased by $80,000,  or 29%, to $356,000 from $276,000
in the year ago  period.  The  increase  was due  primarily  to an  increase  in
professional  fees of  approximately  $99,000  which was  partially  offset by a
decrease in insurance expense of approximately $13,000.

     Interest  expense  decreased  by $34,000 to $38,000 from $72,000 due to the
repayment of a note payable to an affiliate.  The unrealized  loss on marketable
securities  of $606,000 in 1994  represents a decline in the market price of the
TCC Common Stock owned by the Company.  As of October 31, 1994 with the adoption
of SFAS No.  115,  such  unrealized  losses (or  unrealized  gains,  if any) are
reported in a separate component of shareholders'  equity (see Note 2 and Note 4
of Notes to Consolidated Condensed Financial Statements).

CAPITAL RESOURCES AND LIQUIDITY:

     During the  fiscal  year  ended  October  31,  1993 the  Company  used cash
primarily to acquire its majority  interest in the mortgage banking business and
in the fiscal year ended October 31, 1992,  cash was used  primarily to fund the
Company's general and administrative  expenses.  Due to the sale of its mortgage
banking  business in November 1994, the Company  anticipates  that its principal
financing needs in fiscal 1995 will consist primarily of funding its general and
administrative  expenses and, possibly, the acquisition price of one or more new
business  activities  (see Note 1 of Notes to Consolidated  Condensed  Financial
Statements).

     The Company  believes  that cash on hand,  including the cash proceeds from
the sale of the majority of its mortgage banking business in November 1994, will
be sufficient to finance its general and  administrative  expenses during fiscal
1995.  However, in order to provide the financing required to enable the Company
to acquire one or more new business  activities  during fiscal 1995, the Company
will need to utilize  shares of TCC Common  Stock  which are owned by it through
sales of such  shares  from  time to time in the  open  market  (depending  upon
prevailing market  conditions) and/or as all or part of the acquisition price of
a business that the Company may seek to acquire.

     The Company did not have any material  capital  commitments  at January 31,
1995.

INFLATION AND CHANGING PRICES:

     The Company has not been materially affected by inflation.

                                       9

<PAGE>


PART II. OTHER INFORMATION

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

a.       Exhibits

<TABLE>
<CAPTION>
         Exhibit
         Number     Description
         -------    -----------
         <S>        <C>                                                                    
         10.22      Promissory  Note of the Company in the  principal  amount of
                    $1.5 million, payable to the order of Commercial Bank of New
                    York, dated January 31, 1995.

         10.23      Corporate  Governance  Agreement,  dated as of February  28,
                    1995,  by and  among  the  Company,  Unistar  Gaming  Corp.,
                    Watermark Investments Limited, and James W. Spencer.

         27         Financial Data Schedule
</TABLE>

b. A Form 8-K, dated December 13, 1994 and a Form 8-K/A, dated February 10, 1995
were filed by the Company  during the quarter for which this report on Form 10-Q
is filed.  Reported  on said  Forms  were  Disposition  of Assets  and Pro Forma
Financial Information.


                                       10

<PAGE>


                                   SIGNATURES



Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


                                                      COOPER LIFE SCIENCES, INC.
                                                      --------------------------
                                                              (REGISTRANT)



Date:  March 14, 1995                            By:    /s/  Steven Rosenberg
       --------------                                  ------------------------
                                                       STEVEN ROSENBERG
                                                       VICE PRESIDENT AND CHIEF
                                                       FINANCIAL OFFICER



                                       11

<PAGE>

                                 EXHIBIT INDEX

<TABLE>
<CAPTION>
Exhibit
Number            Description                                        Sequential
--------          -----------                                       Page Number
                                                                    -----------
<S>               <C>                                               <C>
10.22             Promissory Note of the Company in the
                  principal amount of $1.5 million, payable
                  to the order of Commercial Bank of New York,
                  dated January 31, 1995.

10.23             Corporate Governance Agreement, dated as of
                  February 28, 1995, by and among the Company,
                  Unistar Gaming Corp., Watermark Investments
                  Limited, and James W. Spencer.

27                Financial Data Schedule
</TABLE>

                                       12



<PAGE>
 
[Logo] Commercial Bank             COLLATERAL NOTE
       of New York        (Single Payment -- Demand or Time)
                             (Variable Rate of Interest)
 
                                                   New York, NY January 31, 1995
 
$1,500,000
 
   On  May 1, 1995  , for value  received, the undersigned  promise(s) to pay to
Commercial Bank of New York (hereinafter called the 'Bank') or order, at its 404
5th Ave. office, in New York, NY 10018 in lawful money of the United States  the
principal  amount  of  ONE MILLION  FIVE  HUNDRED THOUSAND  AND  00/100 Dollars,
($1,500,000.00) with interest from the date of this note to maturity (whether as
stated above or by acceleration) or demand  (if this note is payable on  demand)
at  a rate per annum equal to 1.5 percent  above the prime loan rate of the Bank
from time to time in effect calculated on the basis of a 360-day year and actual
number of days elapsed (but in no event in excess of the maximum rate  permitted
by applicable law), such interest to be payable monthly commencing FEBRUARY 1995
and  continuing  on  the same  day  of  each calendar  month  thereafter  and at
maturity. If the space in the  preceding sentence is incomplete or completed  by
the  insertion of a  '0' or a mark  other than a number,  then the interest rate
hereunder shall be equal to the prime loan rate of the Bank in effect from  time
to  time. Any change in such  rate of interest shall be  effective on the date a
change i  the  prime  loan rate  of  the  Bank occurs,  without  notice  to  the
undersigned.  Interest  from  and  after  maturity  (whether  as  stated  or  by
acceleration) or demand (if this note is payable on demand) shall be at the rate
of 24%  per annum  or if  such rate  shall not  be lawful  with respect  to  the
undersigned,  at the highest lawful rate then  in effect. The prime loan rate of
the Bank in effect on the date of this note is 8.5% per annum.
 
   The undersigned has pledged, granted a security interest or deposited with or
delivered to  the Bank  as security  for the  payment of  this note  and of  all
Liabilities of the undersigned to the Bank the following property,
 
               COOPER COMPANIES COMMON STOCK -- 1,500,000 SHARES
--------------------------------------------------------------------------------
 
--------------------------------------------------------------------------------
 
--------------------------------------------------------------------------------
 
   The  term 'Liabilities' shall  include this note  and all other indebtedness,
obligations and liabilities of any kind of the undersigned to the Bank and  also
to  others to the extent of their participations granted to or interests therein
created or acquired  for them by  the Bank, now  or hereafter existing,  arising
directly   between  the   undersigned  and   the  Bank   or  acquired  outright,
conditionally or as collateral  security from another by  the Bank, absolute  or
contingent,  joint  and/or several,  secured  or unsecured,  due  contractual or
tortious, liquidated, arising  by operation of  law or otherwise,  or direct  or
indirect,  including liabilities to the  Bank of the undersigned  as a member of
any partnership, syndicate, association or other group, and whether incurred  by
the  undersigned as principal, surety,  endorser, guarantor, accommodation party
or otherwise.  The  term 'Security'  shall  include the  property  described  or
referred  to above and the  balance of every deposit  account of the undersigned
with the Bank and any  other claim of the undersigned  against the Bank, now  or
hereafter  existing, and all money,  instruments, securities, documents, chattel
paper, credits, claims, demands and any other property, rights and interests  of
the  undersigned which at any time shall  come into the possession or custody or
under  the  control  of   the  Bank  or  any   of  its  agents,  associates   or
correspondents,  for any purpose, and shall include the proceeds of any thereof.
The Bank shall be deemed to have possession of any of the Security in transit to
or set apart for it or any of its agents, associates or correspondents.
 
   As security for the  payment of all the  Liabilities, the undersigned  hereby
grant(s)  to the  Bank a security  interest in,  and a general  lien upon and/or
right of set-off of, the Security.
 
   The right is expressly granted to the Bank, at its discretion, to transfer to
or register  in the  name of  itself or  its nominee  any of  the Security,  and
whether  or not so transferred or registered to receive the income and dividends
thereon, including stock dividends and rights to subscribe, and to hold the same
as a part  of the Security  and/or apply  the same as  hereinafter provided;  to
exchange   any  of  the   Security  for  other   property  upon  reorganization,
recapitalization or other  readjustment and in  connection therewith to  deposit
any  of the Security with any committee or  depository upon such terms as it may
determine; to vote the Security so transferred or registered and to exercise  or
cause  its nominee to exercise  all or any powers  with respect thereto with the
same force  and effect  as an  absolute owner  thereof; all  without notice  and
without  liability except to  account for property actually  received by it. The
right is expressly granted to the Bank, at its discretion and without notice  to
or  containing the signature  of the undersigned  to file one  or more financing
statements under the Uniform  Commercial Code naming  the undersigned as  debtor
and the Bank as secured party and indicating therein the types or describing the
items of the Security herein specified. Without the prior written consent of the
Bank  the undersigned will  not file or authorize  or permit to  be filed in any
jurisdiction any such financing or like statement in which the Bank is not named
as the sole secured party.
 
   The Bank, at its discretion  may, whether any of  the Liabilities be due,  in
its  name  or in  the name  of the  undersigned or  otherwise, demand,  sue for,
collect or receive any money  or property at any  time payable or receivable  on
account  of or  in exchange  for, or  make any  compromise or  settlement deemed
desirable with respect to, any of the Security, but shall be under no obligation
so to do, or  the Bank may extend  the time of payment,  arrange for payment  in
installments, or otherwise modify the terms of, or release, any of the Security,
without  thereby  incurring  responsibility  to,  or  discharging  or  otherwise
affecting any liability of  the undersigned. The Bank  shall not be required  to
take  any steps necessary to preserve any rights against prior parties to any of
the  Security.  Upon  default  hereunder  or  in  connection  with  any  of  the
Liabilities  (whether such default  be that of  the undersigned or  of any other
party obligated thereof), the Bank shall  have the rights and remedies  provided
by  law; and the Bank may sell or cause  to be sold in the Borough of Manhattan,
New York City, or elsewhere, in one or  more sales or parcels, at such price  as
the  Bank may deem best,  and for cash or on  credit or future delivery, without
assumption of any credit risk all or any of the Security, at any brokers'  board
or  at  public or  private  sale, without  demand  of performance  or  notice of
intention to sell or of time or place of sale (except such notice as is required
by applicable statute and cannot be waived), and the Bank or anyone else may  be
the purchaser of any or all of the Security so sold and thereafter hold the same
absolutely,  free  from any  claim or  right of  whatsoever kind,  including any
equity of redemption, of the undersigned,  any such demand, notice or right  and
equity  being hereby waived and  released. The undersigned will  pay to the Bank
all expenses  (including  expense for  legal  services  of every  kind)  of,  or
incidental  to, the enforcement of any of the provisions hereof or of any of the
Liabilities, or  any actual  or attempted  sale, or  any exchange,  enforcement,
collection,  compromise or settlement of  any of the Security  or receipt of the
proceeds thereof, and for  the care of the  Security and defending or  asserting
the  rights  and  claims  of  the Bank  in  respect  thereof,  by  litigation or
otherwise, including  expense  of insurance,  and  all such  expenses  shall  be
indebtedness  within the terms of  the this note. The Bank,  at any time, at its
option, may apply  the net cash  receipts from  the Security to  the payment  of
principal  of and/or interests  on any of  the Liabilities, whether  or not then
due, making  proper rebate  of interest  or discount.  Notwithstanding that  the
Bank,  whether in its own  behalf and/or in behalf  of another and/or of others,
may continue  to  hold  Security  and  regardless  of  the  value  thereof,  the
undersigned  shall be and  remain liable of  the payment in  full, principal and
interest, of any balance of the Liabilities and expenses at any time unpaid.
 
<PAGE>
   If at any time the Security shall be unsatisfactory to the Bank, upon  demand
of  the Bank  the undersigned  will furnish such  further security  or make such
payment on account  of any of  the Liabilities  as will be  satisfactory to  the
Bank,  and if the undersigned  fail(s) forthwith to furnish  such security or to
make such payment; or if any sum payable upon any of the Liabilities be not paid
when due;  or if  the undersigned,  or any  maker, drawer,  acceptor,  endorser,
guarantor, surety, accommodation party or other person liable upon or for any of
the  liabilities or Security  (each hereinafter called  an 'other liable party')
shall die, become insolvent (however such insolvency may be evidenced), fail  to
pay  any debt  as such  debts become due  or make  a general  assignment for the
benefit of creditors; or  if the undersigned or  any copartnership or which  the
undersigned  is (are) a member or members  shall suspend the transaction of his,
its or their usual business,  or be expelled from or  suspended by any stock  or
securities  exchange or other  exchange, or any  proceeding, procedure or remedy
supplementary to  or  in  enforcement  of judgement  shall  be  resorted  to  or
commenced  against, or with respect  to any property of,  the undersigned or any
such copartnership or other liable party; or if a petition in bankruptcy or  for
any  relief under  any law  relating to the  relief of  debtors, readjustment of
indebtedness, reorganization, composition  or extension shall  be filed, or  any
proceeding shall be instituted under any such law, by or against the undersigned
or  any  such  copartnership  or  other liable  party;  or  if  any governmental
authority or any  court at  the instance thereof  shall take  possession of  any
substantial  part of  the property  of, or  assume control  over the  affairs or
operations of, or a receiver shall be appointed of, or of a substantial part  of
the property of, or a writ or order of attachment or garnishment shall be issued
or made against any of the property of, the undersigned or other liable partner;
or  if  there shall  be  such a  change in  the  financial condition  or affairs
(personal  or  otherwise)  which  in  the  opinion  of  the  Bank  impairs   the
collectability of this note or increases its risk; or if any indebtedness of the
undersigned  or any such copartnership or  other liable party for borrowed money
shall become due  and payable  by acceleration of  maturity thereof;  or if  the
undersigned  conceals, removes or permits to be concealed or removed any part of
the undersigned's property with  intent to hinder, delay  or defraud any of  its
creditors;  or the making or  suffering by the undersigned  of a transfer of any
property, which  is fraudulent  under the  law of  any applicable  jurisdiction;
thereupon,  unless and to the extent that the Bank shall otherwise elect, all of
the Liabilities shall become and be due and payable forthwith.
 
   The Bank may assign, transfer and/or deliver to any transferee of any of  the
Liabilities any or all of the Security, and thereafter shall be fully discharged
from  all responsibility with respect to such Security. Such transferee shall be
vested with all the powers and rights of the Bank hereunder with respect to such
Security, but the  Bank shall  retain all rights  and powers  hereby given  with
respect to any of the Security not so assigned, transferred and/or delivered. No
delay  on the part of the Bank in exercising any power or rights hereunder shall
operate as a  waive thereof; nor  shall any  single or partial  exercise of  any
power  or  right hereunder  preclude other  or further  exercise thereof  or the
exercise of any other power or  right. The rights, remedies and benefits  herein
expressly  specified are cumulative and not exclusive of any rights, remedies or
benefits which  the Bank  may otherwise  have. The  undersigned hereby  waive(s)
presentment,  notice of dishonor  and protest of all  instruments included in or
evidencing the Liabilities  or the Security  and any and  all other notices  and
demands whatsoever, whether or not relating to any such instrument.
 
   In  the event  any payment  provided for  herein shall  become overdue  for a
period in excess  of five  (5) days, a  late charge  of six (6)  cents for  each
dollar so overdue shall become immediately due to Bank as liquidated damages for
failure  to make prompt payment, and the  same shall be part of the Liabilities.
Late charge  shall be  payable with  the next  installment of  principal  and/or
interest due hereunder.
 
   Each  of the undersigned and any endorser hereof agree that if an attorney is
sued to  enforce or  collect this  note a  reasonable attorney's  fee and  legal
expenses shall be added thereto.
 
   The  Bank may apply any payments received  hereunder to the payment, in whole
or in part, of all amounts  due hereunder including interest, principal and  all
costs  and fees, including attorney's fees, in such order as Bank may elect, and
the undersigned waives the right to direct or object to any such application  of
payments.
 
   The  Bank shall have the right to sell a participation in or assign this note
without the consent of the undersigned and the undersigned hereby consents  that
the  Bank may  disclose any  credit or  financial information  within the Bank's
possession to any prospective participant or assignee of this note.
 
   Each of the undersigned in any litigation  (whether or not arising out of  or
relating  to this note or any other  obligations or liability of the undersigned
to the Bank) in which the Bank and any of them shall be adverse parties,  waives
trial by jury and the right to interpose any defense, set-off or counterclaim of
any nature or description.
 
   No  provision  hereof  shall  be  modified or  limited  except  by  a written
instrument expressly  referring  hereto and  to  the provision  so  modified  or
limited.  The  undersigned, if  more than  one, shall  be jointly  and severally
liable hereunder and all provisions hereof regarding the Liabilities or Security
of the undersigned shall apply to any Liability or any Security of any or all of
them. This note  and the provisions  hereof are  to be binding  upon the  heirs,
executors,  administrators, assigns or successors of the undersigned; they shall
continue in force notwithstanding  any change in  any partnership party  hereto,
whether  such change occurs through death, retirement or otherwise; and they are
to be construed according to and governed by the laws of the State of New York.
 
 
                                          By: STEVEN ROSENBERG, Vice President
                                              --------------------------------
                                              COOPER LIFE SCIENCES, INC.
                                              --------------------------------
NO.                DUE                        Address 160 Broadway
    -------------      -------------          --------------------------------
                                              New York, NY 10038

                                                                 Member F.D.I.C.
 
LN6 (5/91)



<PAGE>
                         CORPORATE GOVERNANCE AGREEMENT
 
     AGREEMENT,  dated as of the 28th day of February, 1995, by and among Cooper
Life Sciences, Inc.,  a Delaware  corporation ('CLS'), Unistar  Gaming Corp.,  a
Delaware  corporation  ('UGC'),  Watermark  Investments  Limited,  a corporation
organized under the laws of the  Commonwealth of the Bahamas ('Watermark'),  and
James W. Spencer ('Spencer').
 
                                W I T N E S S E T H :
 
     WHEREAS, pursuant to the terms of the Agreement and Plan of Reorganization,
dated  as  of the  28th  day of  February, 1995,  by  and among  UGC, Watermark,
Spencer, Unistar Entertainment,  Inc., a Colorado  corporation ('Unistar'),  and
UEI  Acquisitionco,  Inc.,  a  Colorado  corporation  ('Acquisitionco'),  at the
effective time  of  the merger  of  Acquisitionco  with and  into  Unistar  (the
'Merger'),  all of the issued and outstanding  shares of Common Stock of Unistar
will be automatically converted into shares of Common Stock of UGC; and
 
<PAGE>
WHEREAS, as the stockholders of Unistar, Watermark and Spencer will acquire,  as
a  result of said Merger, an aggregate of 6,178,130 newly issued and outstanding
shares of UGC representing approximately  72.5% of the outstanding Common  Stock
of UGC; and
 
WHEREAS, at the effective time of the Merger, CLS will be the owner of 2,343,695
shares  of  Common  Stock  of  UGC,  representing  approximately  27.5%  of  the
outstanding Common Stock of UGC; and
 
WHEREAS,  in  connection  with  the  implementation  of  the  Merger,  CLS   has
transferred  cash and property to UGC having an aggregate value of approximately
$5 million; and
 
WHEREAS, it is CLS' intention to  distribute substantially all of the shares  of
UGC  Common Stock  which are  owned by CLS  to its  stockholders, on  a pro rata
basis; and
 
WHEREAS, subparagraph 6.4 of the  Agreement and Plan of Reorganization  provides
for the execution and delivery of this Agreement.
 
NOW,  THEREFORE, in consideration  of and in  reliance upon the representations,
warranties and covenants herein and  in the Reorganization Agreement  contained,
the parties hereto hereby agree as follows:
 
     1. UGC Board Representation.
 
           1.1  CLS Designees. During  the period commencing  on the date hereof
and terminating on the sixth anniversary of the date hereof, UGC, Watermark  and
Spencer  shall, if requested by CLS, each use his or its reasonable best efforts
to cause the nomination and election to UGC's Board of Directors of a number  of
persons  who are designated by CLS which shall be equal to one-third (rounded up
to the nearest whole number) of UGC's entire Board of Directors (i.e., one-third
of the number of members of the Board of Directors if there were no vacancies on
the Board).
 
           1.2 Election of Designees. In connection with the rights of CLS which
are described in subparagraph 1.1 above:
 
             (i) UGC shall only  be obligated to nominate  designees of CLS  who
        are reasonably acceptable to UGC;
 
             (ii) Watermark and Spencer shall each vote or cause to be voted all
        shares  of UGC Common Stock which (a) are owned by them, beneficially or
        of record, or (b) either of them otherwise has the power or authority to
        vote, for the election of CLS' designees for election to UGC's Board  of
        Directors;
 
             (iii)  In the  event that  any Director  who is  a designee  of CLS
        ceases to be a member of UGC's  Board of Directors, by reason of  death,
        resignation,   retirement,  disqualification,  removal  from  office  or
        otherwise, then in such event, the vacancy created thereby shall be,  as
        soon as is practicable, filled by a person who is a designee of CLS;
 
             (iv) Whenever necessary to maintain the proportionality required by
        subparagraph 1.1 above: (A) CLS shall cause one or more of the Directors
        who  are designated by it to resign  from the Board of Directors of UGC;
        and (B)  UGC shall  cause the  Board  of Directors  to be  increased  or
        decreased in size, as appropriate;
 
                                       2
 
<PAGE>
(v)  The respective obligations of Watermark and Spencer to vote their shares of
UGC Common Stock as provided in clause (ii) above shall automatically  terminate
with respect to any of such shares of UGC Common Stock which are, after the date
hereof,  sold by either of  them to an unrelated  third party in an arm's-length
transaction or in a public offering  pursuant to a Registration Statement  under
the  Securities Act of 1933, as amended (unless they retain the right to vote or
reacquire such shares). Subject to the foregoing, neither Watermark nor  Spencer
shall  sell or otherwise transfer any of their shares of UGC Common Stock unless
the transferee shall have first executed  and delivered a written agreement,  in
form  and  substance satisfactory  to CLS,  to the  effect that  said transferee
agrees to be bound by the terms hereof; and
 
(vi) Watermark and Spencer each hereby agrees that the certificates representing
their shares of  UGC Common Stock  shall bear a  legend to the  effect that  the
right  to vote the shares  represented thereby are subject  to the provisions of
this Agreement.
 
        2. Certain Covenants. UGC, Watermark and Spencer each hereby agrees  (i)
not to take any action, direct or indirect, which would be inconsistent with the
provisions hereof, and (ii) to take all such actions, and to execute and deliver
all  such  documents and  instruments  (including, in  the  case of  Spencer and
Watermark, but not limited to, written  consents as stockholders of UGC),  which
CLS  may at  any time  and from time  to time  after the  date hereof reasonably
request in order  to more fully  perfect or  protect the rights  intended to  be
granted to CLS pursuant to this Agreement.
 
     3.  General  Provisions. 3.1  Notices. All  notices, requests,  demands and
other communications hereunder shall be in  writing and shall be deemed to  have
been  duly given  or made  as of  the date  delivered, transmitted  or mailed if
delivered personally, transmitted by telecopier (with confirmation of  receipt),
or  mailed  by registered  or certified  mail,  postage prepaid,  return receipt
requested, as follows:
 
          If to UGC, to:
 
          Unistar Gaming Corp.
     160 Broadway
     New York, New York 10038
     Telecopier No.: (212) 791-5367
 
                                       3
 
<PAGE>
          Copy to:
     Tenzer Greenblatt LLP
     405 Lexington Avenue
     New York, New York 10174
     Telecopier No.: (212) 573-4313
     Attention: Harold L. Schneider, Esq.
 
          If to Watermark, to:
     Watermark Investments Limited
     Bahamas International Trust Co.
     Bank Lane
     Nassau, Bahamas
     Telecopier No.: (809) 326-5020
     Attention: Ms. Veronica Moncur
 
          Copy to:
     Varner, Stephens, Humphries & White
     Suite 1700 Riverwood
     3350 Cumberland Circle
     Atlanta, Georgia 30339
     Telecopier No.: (404) 850-7070
     Attention: William W. Hopson, Esq.
 
          If to Spencer, to:
     Mr. James W. Spencer
     8446 Bronze Lane
     Highlands Ranch, Colorado 80126
 
          Copy to:
     Kreutz & Associates, P.C.
     5655 South Yosemite Street
     Suite 200
     Englewood, Colorado 80111
     Telecopier No.: (303) 793-0923
     Attention: James K. Kreutz, Esq.
 
        3.2 Governing Law. This Agreement shall be governed by and construed  in
accordance with the laws of the State of Delaware.
 
                                       4
 
<PAGE>
        3.3  Entire Aqreement. This Agreement sets forth the entire agreement of
the parties hereto with respect to the subject matter hereof and supersedes  all
prior agreements with respect thereto.
 
        3.4  Amendments.  This  Agreement  may  only  be  amended  by  a written
instrument executed by all of the parties hereto.
 
        3.5 Waivers. No failure or delay  by any party in exercising any  right,
power  or privilege hereunder  shall operate as  a waiver thereof  nor shall any
single or  partial  exercise thereof  preclude  any other  or  further  exercise
thereof  or the exercise of any other  right, power or privilege. The rights and
remedies herein provided shall be cumulative and not exclusive of any rights  or
remedies provided by law.
 
        3.6  Specific  Performance. Each  of UGC,  Watermark and  Spencer hereby
acknowledges and agrees  that CLS' remedies  at law for  a breach or  threatened
breach  of any of the  provisions of this Agreement  would be inadequate and, in
recognition of that fact, agrees  that, in the event  of a breach or  threatened
breach  by any of them  of the provisions of this  Agreement, in addition to any
remedies at law,  CLS, without  posting any bond,  shall be  entitled to  obtain
equitable  relief in the  form of specific  performance, a temporary restraining
order, a temporary or permanent injunction or any other remedy which may then be
available.
 
        3.7 Assignment. This Agreement shall be  binding upon, and inure to  the
benefit  of,  the  parties hereto  and  CLS  and their  respective  heirs, legal
representatives, successors and assigns.
 
        3.8 Headings. The headings contained herein are for the sole purpose  of
convenience  of reference, and shall not in  any way limit or effect the meaning
or interpretation of any of the terms or provisions of this Agreement.
 
        3.9 Counterparts.  This  Agreement  may  be  executed  in  one  or  more
counterparts, and by the different parties hereto in separate counterparts, each
of which shall be deemed to be an original but all of which taken together shall
constitute one and
 
                                       5
 
<PAGE>
the  same agreement and shall become effective when one or more counterparts has
been signed by each of  the parties hereto, and delivered  to each of the  other
parties hereto.
 
        IN  WITNESS WHEREOF, this  Agreement has been  executed and delivered by
parties hereto as of the date first above written.
 
                                          UNISTAR GAMING CORP.
 
                                          By:     MEL SCHNELL
                                            ------------------------------------
 
                                          Name: Mel Schnell
                                            Title:  Chairman and Chief
                                                 Executive Officer
 
                                          WATERMARKS INVESTMENTS LIMITED

                                          By: ROBERT A. BERMAN
                                          --------------------------------------
 
                                          Name: ROBERT A. BERMAN
                                          Title:  Managing Director
 
                                                     JAMES W. SPENCER
                                          --------------------------------------
 
                                                     James W. Spencer
 
AGREED TO AND ACCEPTED AS OF THE DATE ABOVE WRITTEN:
 
COOPER LIFE SCIENCES, INC.
 
By: MEL SCHNELL
    -------------------------------------------------------------
    President
 
                                       6


<TABLE> <S> <C>

<ARTICLE>                              5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE COOPER
LIFE SCIENCES, INC. QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD
ENDED JANUARY 31, 1995 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH 
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>                           1,000
       
<S>                                    <C>            <C>
<PERIOD-TYPE>                          3-MOS
<FISCAL-YEAR-END>                      OCT-31-1994
<PERIOD-END>                           JAN-31-1995
<CASH>                                    636
<SECURITIES>                           18,669
<RECEIVABLES>                               0
<ALLOWANCES>                                0
<INVENTORY>                                 0
<CURRENT-ASSETS>                            0
<PP&E>                                     42
<DEPRECIATION>                              3
<TOTAL-ASSETS>                         24,532
<CURRENT-LIABILITIES>                       0
<BONDS>                                     0
<COMMON>                                  251
                       0
                                 0
<OTHER-SE>                             21,530
<TOTAL-LIABILITY-AND-EQUITY>           24,535
<SALES>                                     0
<TOTAL-REVENUES>                           12
<CGS>                                       0
<TOTAL-COSTS>                               0
<OTHER-EXPENSES>                          356
<LOSS-PROVISION>                            0
<INTEREST-EXPENSE>                         38
<INCOME-PRETAX>                         3,268
<INCOME-TAX>                                0
<INCOME-CONTINUING>                      (382)
<DISCONTINUED>                          3,650
<EXTRAORDINARY>                             0
<CHANGES>                                   0
<NET-INCOME>                            3,268
<EPS-PRIMARY>                            1.47
<EPS-DILUTED>                            1.47
<FN>
See the financial statements for an unclassified balance sheet.
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission